The analysis of CB2 mRNA levels in the colon cancer patient series indicated that CB2 receptor over-expression is a poor prognostic factor for patients with tumors in advanced stages, patients N+ or patients with tumors that showed vascular invasion. This evidence concerns the gene CNR2 and colonic neoplasm.